As a tumor-targeting system, non-pathogenic E. coli strain MG1655 can deliver TNF-α specifically in tumor sites, thereby localizing its tumor-killing effect and achieving precise control over the targeted therapy [248]. The gene discussed is TNF; the disease is neoplasm.